Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02873819
Title Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gliknik Inc.
Indications

oral squamous cell carcinoma

Therapies

MAGE-A3 vaccine

Cyclophosphamide + Poly ICLC + Sargramostim

Age Groups: adult | senior
Covered Countries USA | ESP


No variant requirements are available.